Latest Lead News

Nido Education Limited has appointed Adam Lai, former PwC Sydney Managing Partner, as its new CEO starting February 2025, signaling a strategic push for significant expansion over the next five to eight years.

Pure Hydrogen advances its zero-emission vehicle strategy with key deliveries, US partnerships, and a planned demerger of its natural gas assets into Eastern Gas Limited.

Amplia Therapeutics has completed enrolment for its ACCENT Phase 2a trial in advanced pancreatic cancer two months early, reporting encouraging partial response rates and improved patient outcomes.

Peel Mining's December 2024 quarterly report reveals exceptional high-grade copper, gold, silver, lead, and zinc intercepts at Wagga Tank, highlighting significant potential for resource expansion within open-pittable depths. Concurrently, fieldwork advances at the Curnamona Project and a solid cash position underpin the company's growth trajectory.

Green Technology Metals (ASX: GT1) secures a Letter of Interest for up to C$100 million financing from Export Development Canada, underpinning its Seymour Lithium Project and advancing drilling and development across its Ontario lithium hubs.

Lendlease has agreed to sell Capella Capital for $235 million and completed the $516 million sale of its US Military Housing business, reinforcing its strategy to streamline operations and reduce funding needs.

ABx Group reports significant progress in its rare earths and bauxite ventures, including enhanced geological models and pilot plant developments supported by key partnerships and government backing.

Lefroy Exploration has reported significant mineral resource upgrades at Burns Central and Mt Martin, alongside a strategic exclusivity agreement with BML Ventures to develop the Lucky Strike Gold Project.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.

Imugene Limited reports durable patient responses in multiple cancer immunotherapy trials and strengthens its financial position with a $46 million convertible note deal and a substantial R&D tax refund.

Sunshine Metals Ltd reports a substantial upgrade to its Ravenswood Consolidated Project, with a 57% rise in contained gold and positive drilling and metallurgical results underpinning the growth.

Vulcan Energy has marked a pivotal quarter with major capital raises, strategic partnerships, and the commencement of Europe’s first fully integrated battery-quality lithium hydroxide production.